Literature DB >> 3871588

Histoplasmosis in the acquired immune deficiency syndrome.

L J Wheat, T G Slama, M L Zeckel.   

Abstract

This report describes the experience with disseminated histoplasmosis in seven of 15 patients with the acquired immune deficiency syndrome (AIDS) diagnosed in Indianapolis since 1981. Three were homosexual, two were intravenous drug addicts, one was the spouse of another patient with AIDS and disseminated histoplasmosis, and the seventh was a hemophiliac. Six had associated infections: candidiasis in three, Pneumocystis carinii pneumonia, recurrent mucocutaneous herpes simplex infection, and disseminated Mycobacterium avium infection in two each, and disseminated infection with an unidentified mycobacterium in one. Clinical diseases suggested sepsis in four. Histoplasma fungemia occurred in five, but the diagnosis was established first by visualization of organisms in blood or bone marrow in three. Results of Histoplasma serologic tests were positive in each. Three died before receiving 50 mg of amphotericin B, three had prompt improvement with amphotericin B, and one was treated with ketoconazole to prevent dissemination. However, two of the three patients treated with amphotericin B had relapses after a 35 mg/kg course, and the third died within a month following therapy. Disseminated histoplasmosis is a major opportunistic infection in patients with AIDS from endemic areas. AIDS should be strongly considered in otherwise healthy persons with disseminated histoplasmosis, especially if risk factors for AIDS are present. Amphotericin B is not curative in these patients.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3871588     DOI: 10.1016/0002-9343(85)90427-9

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  29 in total

1.  Histoplasmosis infections worldwide: thinking outside of the Ohio River valley.

Authors:  Nathan C Bahr; Spinello Antinori; L Joseph Wheat; George A Sarosi
Journal:  Curr Trop Med Rep       Date:  2015-06-01

Review 2.  Immunosuppression related to collagen-vascular disease or its treatment.

Authors:  Carol Dukes Hamilton
Journal:  Proc Am Thorac Soc       Date:  2005

3.  Histoplasmosis of the central nervous system.

Authors:  V Tan; P Wilkins; S Badve; M Coppen; S Lucas; R Hay; F Schon
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-07       Impact factor: 10.154

Review 4.  AIDS and the lung. 4-- Non-invasive investigation of pulmonary disease in patients positive for the human immunodeficiency virus.

Authors:  A B Millar; D M Mitchell
Journal:  Thorax       Date:  1990-01       Impact factor: 9.139

5.  Histoplasmosis in HIV-Infected Patients: Epidemiological, Clinical and Necropsy Data from a Brazilian Teaching Hospital.

Authors:  Alessandro Henrique Damasceno-Escoura; Delio José Mora; Anderson Clayton Cardeal; Júlio Cesar Berto-Nascimento; Renata Margarida Etchebehere; Antônio Carlos Oliveira de Meneses; Sheila Jorge Adad; Adilha Misson Rua Micheletti; Mario León Silva-Vergara
Journal:  Mycopathologia       Date:  2020-02-20       Impact factor: 2.574

6.  HISTOPLASMOSIS IN ACQUIRED IMMUNODEFICIENCY SYNDROME.

Authors:  R Mohanchand; A P Singh; T K Salopal
Journal:  Med J Armed Forces India       Date:  2017-06-10

7.  Coccidioidomycotic brain abscess in an HIV-infected man.

Authors:  J G Jarvik; J R Hesselink; C Wiley; S Mercer; B Robbins; P Higginbottom
Journal:  West J Med       Date:  1988-07

8.  Vbeta4(+) T cells promote clearance of infection in murine pulmonary histoplasmosis.

Authors:  F J Gomez; J A Cain; R Gibbons; R Allendoerfer; G S Deepe
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

9.  Histoplasmosis in individuals with acquired immunodeficiency syndrome (AIDS): report of six cases with cutaneous-mucosal involvement.

Authors:  A A Machado; I C Coelho; A M Roselino; E S Trad; J F Figueiredo; R Martinez; J C de Costa
Journal:  Mycopathologia       Date:  1991-07       Impact factor: 2.574

10.  WI-1, a novel 120-kilodalton surface protein on Blastomyces dermatitidis yeast cells, is a target antigen of cell-mediated immunity in human blastomycosis.

Authors:  B S Klein; P M Sondel; J M Jones
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.